Dr Louise Marquart-Wilson
Dr

Louise Marquart-Wilson

Email: 
Phone: 
+61 7 334 64687

Availability

Dr Louise Marquart-Wilson is:
Available for supervision
Media expert

Fields of research

Biostatistics Mathematical Sciences Statistics

Qualifications

  • Bachelor of Economics, The University of Queensland
  • Bachelor of Science, The University of Queensland
  • Bachelor (Honours) of Applied Science, Queensland University of Technology
  • Doctor of Philosophy, The University of Queensland
  • Journal Peer-Reviewer, Statistical Methods in Medical Research, Statistical Methods in Medical Research
  • Member, Statistical Society of Australia, Statistical Society of Australia

Research interests

  • Generalised linear mixed effects models

    Research focusing on the application, extension and evaluating statistical performance of generalised mixed effects models (GLMMs) within medical and public health applications. GLMMs are a flexible statistical methodology to account for hierarchical structure that are inherent in some datasets. GLMMs can be used for the analysis of longitudinal data, and can be utilised when there is additional hierarchical structure (i.e. repeated measures of people nested within clusters). There are four topics within this theme which include: 1. Investigating the impact of violating assumptions of GLMMs, 2. linear and non-linear mixed effects models for malaria parasite dynamics, 3. segmented mixed effects models (interrupted time series), and 4. analysis of repeated measures patient reported outcome measures.

Search Professor Louise Marquart-Wilson’s works on UQ eSpace

113 works between 2010 and 2025
All (113) Journal Article (104) Conference Publication (7) Other Outputs (2)

1 - 20 of 113 works

2025

Journal Article

Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival

Vaz-Gonçalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda M, Stephensen, Meghan T, Moore, Julie, Morris, Michelle F, Saunus, Jodi M and Reeves, Marina M (2025). Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival. Journal of Cancer Policy, 44 100567, 100567-44. doi: 10.1016/j.jcpo.2025.100567

Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival

2025

Journal Article

Mean relative error and standard relative deviation

Chatfield, Mark D., Marquart‐Wilson, Louise, Dobson, Annette J. and Farewell, Daniel M. (2025). Mean relative error and standard relative deviation. Statistica Neerlandica, 79 (1) e70001, 1-7. doi: 10.1111/stan.70001

Mean relative error and standard relative deviation

2024

Journal Article

Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage <i>Plasmodium falciparum</i> to predict efficacy in patients with malaria

Abd-Rahman, Azrin N., Kaschek, Daniel, Kummel, Anne, Webster, Rebecca, Potter, Adam J., Odedra, Anand, Woolley, Stephen D., Llewellyn, Stacey, Webb, Lachlan, Marquart, Louise, Chalon, Stephan, El Gaaloul, Myriam, Mccarthy, James S., Mohrle, Jorg J. and Barber, Bridget E. (2024). Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria. Bmc Medicine, 22 (1) 563. doi: 10.1186/s12916-024-03787-0

Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage <i>Plasmodium falciparum</i> to predict efficacy in patients with malaria

2024

Conference Publication

Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort

Vaz-Goncalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda M., Saunus, Jodi M., Moore, Julie, Morris, Michelle J. and Reeves, Marina M. (2024). Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort

2024

Journal Article

Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54

Colditz, Paul B., Boyd, Roslyn N., Winter, Leanne, Pritchard, Margo, Gray, Peter H., Whittingham, Koa, O’Callaghan, Michael, Jardine, Luke, O’Rourke, Peter, Marquart, Louise, Forrest, Kylee, Spry, Carmen and Sanders, Matthew R. (2024). Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54. The Journal of Pediatrics, 275 114293, 114293. doi: 10.1016/j.jpeds.2024.114293

Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54

2024

Journal Article

Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors

D'cunha, Kelly, Park, Yikyung, Leech, Rebecca M., Protani, Melinda M., Marquart-Wilson, Louise and Reeves, Marina M. (2024). Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors. Journal of Cancer Survivorship. doi: 10.1007/s11764-024-01680-6

Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors

2024

Conference Publication

Investigating survival by breast cancer molecular subtype in Australia: A population-based study

Vaz-Goncalves, L., Marquart-Wilson, L., Protani, M., Stephensen, M., Saunus, J., Moore, J., Morris, M. and Reeves, M. (2024). Investigating survival by breast cancer molecular subtype in Australia: A population-based study. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.237

Investigating survival by breast cancer molecular subtype in Australia: A population-based study

2024

Journal Article

Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer

Tuesley, Karen M., Spilsbury, Katrina, Webb, Penelope M., Pearson, Sallie-Anne, Donovan, Peter, Coory, Michael D., Steer, Christopher B., Stewart, Louise M., Pandeya, Nirmala, Protani, Melinda M., Dixon-Suen, Suzanne, Marquart-Wilson, Louise and Jordan, Susan J. (2024). Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer. International Journal of Epidemiology, 53 (4) dyae108, 1-10. doi: 10.1093/ije/dyae108

Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer

2024

Journal Article

Longitudinal changes in iron homeostasis in human experimental and clinical malaria

Woolley, Stephen D., Grigg, Matthew J., Marquart, Louise, Gower, Jeremy S.E., Piera, Kim, Nair, Arya Sheela, Amante, Fiona M., Rajahram, Giri S., William, Timothy, Frazer, David M., Chalon, Stephan, McCarthy, James S., Anstey, Nicholas M. and Barber, Bridget E. (2024). Longitudinal changes in iron homeostasis in human experimental and clinical malaria. eBioMedicine, 105 105189, 1-12. doi: 10.1016/j.ebiom.2024.105189

Longitudinal changes in iron homeostasis in human experimental and clinical malaria

2023

Journal Article

Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models

Yin, Xiaoyan, Li, Ying, Bagchus, Wilhelmina, Yalkinoglu, Özkan, Bezuidenhout, Deon, Tappert, Aliona, McCarthy, James, Marquart, Louise and Oeuvray, Claude (2023). Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models. Malaria Journal, 22 (1) 199, 199. doi: 10.1186/s12936-023-04627-x

Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models

2023

Journal Article

Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis

Matthews, Robyn, Gavin, Nicole C., Marsh, Nicole, Marquart-Wilson, Louise and Keogh, Samantha (2023). Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis. Infection, Disease and Health, 28 (4), 298-307. doi: 10.1016/j.idh.2023.05.005

Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis

2023

Journal Article

Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial

Gavin, Nicole C., Wignall, Elizabeth, Marsh, Nicole, Marquart, Louise, Dobeli, Karen L., O'Brien, Catherine, Verderosa, Anthony D., Totsika, Makrina and Keogh, Samantha (2023). Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial. The Journal of Vascular Access, 25 (5) 11297298231171422, 1519-1527. doi: 10.1177/11297298231171422

Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial

2023

Journal Article

blandaltman: a command to create variants of Bland–Altman plots

Chatfield, Mark D., Cole, Tim J., de Vet, Henrica C. W., Marquart-Wilson, Louise and Farewell, Daniel M. (2023). blandaltman: a command to create variants of Bland–Altman plots. The Stata Journal, 23 (3), 851-874. doi: 10.1177/1536867x231196488

blandaltman: a command to create variants of Bland–Altman plots

2023

Conference Publication

Prevalence and Change in Circadian Rhythm Disrupting Sleep and Eating Behaviours in Breast Cancer Survivors Following a Weight Loss Intervention

D'cunha, Kelly, Park, Yikyung, Leech, Rebecca, Protani, Melinda, Marquart-Wilson, Louise and Reeves, Marina (2023). Prevalence and Change in Circadian Rhythm Disrupting Sleep and Eating Behaviours in Breast Cancer Survivors Following a Weight Loss Intervention. Nutrition 2023, Boston, MA, United States, 22-25 July 2023. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.cdnut.2023.100724

Prevalence and Change in Circadian Rhythm Disrupting Sleep and Eating Behaviours in Breast Cancer Survivors Following a Weight Loss Intervention

2023

Journal Article

Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum

Barber, Bridget E, Abd-Rahman, Azrin N, Webster, Rebecca, Potter, Adam J, Llewellyn, Stacey, Marquart, Louise, Sahai, Nischal, Leelasena, Indika, Birrell, Geoffrey W, Edstein, Michael D, Shanks, G. Dennis, Wesche, David, Moehrle, Joerg J. and McCarthy, James S. (2023). Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum. Clinical Infectious Diseases, 76 (11), 1919-1927. doi: 10.1093/cid/ciad075

Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum

2023

Journal Article

Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum

Webster, Rebecca, Mitchell, Hayley, Peters, Jenny M., Heunis, Juanita, O'Neill, Brighid, Gower, Jeremy, Lynch, Sean, Jennings, Helen, Amante, Fiona H., Llewellyn, Stacey, Marquart, Louise, Potter, Adam J., Birrell, Geoffrey W., Edstein, Michael D., Dennis Shanks, G., McCarthy, James S. and Barber, Bridget E. (2023). Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum. Clinical Infectious Diseases, 76 (3), 506-512. doi: 10.1093/cid/ciac503

Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum

2022

Journal Article

Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients

Shao, E. X., Betz-Stablein, B., Marquat, L., Campbell, S., Isbel, N., Green, A. C. and Plasmeijer, E. I. (2022). Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients. Transplant Immunology, 75 101698, 101698. doi: 10.1016/j.trim.2022.101698

Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients

2022

Journal Article

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Hakkaart, Christopher, Pearson, John F, Marquart, Louise, Dennis, Joe, Wiggins, George A R, Barnes, Daniel R, Robinson, Bridget A, Mace, Peter D, Aittomäki, Kristiina, Andrulis, Irene L, Arun, Banu K, Azzollini, Jacopo, Balmaña, Judith, Barkardottir, Rosa B, Belhadj, Sami, Berger, Lieke, Blok, Marinus J, Boonen, Susanne E, Borde, Julika, Bradbury, Angela R, Brunet, Joan, Buys, Saundra S, Caligo, Maria A, Campbell, Ian, Chung, Wendy K, Claes, Kathleen B M, GEMO Study Collaborators, EMBRACE Collaborators, Collonge-Rame, Marie-Agnès ... Walker, Logan C (2022). Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology, 5 (1) 1061, 1061. doi: 10.1038/s42003-022-03978-6

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

2022

Journal Article

The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination

Marquart, Louise, Webb, Lachlan, O’Rourke, Peter, Gatton, Michelle L., Hsiang, Michelle S., Kalnoky, Michael, Jang, Ihn Kyung, Ntuku, Henry, Mumbengegwi, Davis R., Domingo, Gonzalo J., McCarthy, James S. and Britton, Sumudu (2022). The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination. Malaria Journal, 21 (1) 233, 1-14. doi: 10.1186/s12936-022-04245-z

The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination

2022

Journal Article

Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults

Chughlay, M. Farouk, Barnes, Karen I., El Gaaloul, Myriam, Abla, Nada, Möhrle, Jörg J., Griffin, Paul, van Giersbergen, Paul, Reuter, Stephanie E., Schultz, Hayley B., Kress, Anita, Tapley, Peter, Webster, Rebecca A., Wells, Timothy, McCarthy, James S., Barber, Bridget E., Marquart, Louise, Boyle, Michelle J., Engwerda, Christian R. and Chalon, Stephan (2022). Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults. Antimicrobial Agents and Chemotherapy, 66 (1) e01584-21, e0158421. doi: 10.1128/AAC.01584-21

Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults

Current funding

  • 2024 - 2027
    Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Griffith University)
    Open grant
  • 2024 - 2025
    Feasibility testing Of telehealth-delivered eXercise Therapy for Ostomates Treated for cancer (FOXTROT)
    Wesley Research Institute Ltd
    Open grant

Past funding

  • 2024
    Moving without fear when living with stoma: A consumer-led physical activity study
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2024
    The Enhancing Women's Recovery after Cancer Treatment Program (RECENTRE): A values-based implementation and evaluation
    NHMRC Partnership Projects
    Open grant

Availability

Dr Louise Marquart-Wilson is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding how eating time can influence breast cancer outcomes

    Associate Advisor

    Other advisors: Dr Melinda Protani

  • Doctor Philosophy

    Breakfast to Bed: exploring new ways to improve breast cancer survivorship

    Associate Advisor

    Other advisors: Dr Melinda Protani

  • Doctor Philosophy

    Triple-negative breast cancer in Australia: investigating factors associated with prognosis

    Associate Advisor

    Other advisors: Dr Melinda Protani, Dr Jodi Saunus

  • Doctor Philosophy

    Obesity and triple-negative breast cancer: an epidemiological study

    Associate Advisor

    Other advisors: Dr Jodi Saunus, Dr Melinda Protani

  • Doctor Philosophy

    The usefulness of the percentage difference, 100(lnA - lnB), in health research

    Associate Advisor

    Other advisors: Professor Annette Dobson

Enquiries

Contact Dr Louise Marquart-Wilson directly for media enquiries about:

  • biostatistics
  • interrupted time series
  • longitudinal analysis
  • statistical methodology
  • statistics

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au